Pharmacological behavior of the submaxillary gland and its vasculature of the dog.
D000818:Animals; D001158:Arteries / Q000187:drug effects*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D005731:Ganglionic Stimulants / Q000494:pharmacology; D008297:Male; D009705:Nucleosides / Q000494:pharmacology; D009711:Nucleotides / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D012472:Salivation / Q000187:drug effects; D013363:Submandibular Gland / Q000098:blood supply / Q000187:drug effects*; D013566:Sympathomimetics / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D005730:Ganglionic Blockers; D005731:Ganglionic Stimulants; D009705:Nucleosides; D009711:Nucleotides; D010277:Parasympathomimetics; D010455:Peptides; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents